Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mahal

Showing results (141-150 of 210) with videos related to

Pageof 21
Sort By:
Urologic Oncology|May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imagingVinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
JCO Oncology Practice|November 18, 2022
Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and QualityEdward Christopher Dee, Neil K Taunk, Fumiko L Chino, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Integration of Habitat Risk Score in Radiation Therapy for Prostate CancerEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.
Urologic Oncology|January 5, 2016
Asian Americans and prostate cancer: A nationwide population-based analysisGrace F Chao, Nandita Krishna, Ayal A Aizer, et al.
The Lancet. Digital Health|May 26, 2023
Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysisSmruthy Sivakumar, Jessica K Lee, Jay A Moore, et al.
The American Journal of Medicine|March 21, 2018
Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent DivorceKathryn T Dinh, Ayal A Aizer, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Pageof 21

Showing results (141-150 of 210) with videos related to

Sort By:
Pageof 21
Urologic Oncology|May 21, 2015
Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imagingVinayak Muralidhar, Kathryn T Dinh, Brandon A Mahal, et al.
JCO Oncology Practice|November 18, 2022
Shorter Radiation Regimens and Treatment Noncompletion Among Patients With Breast and Prostate Cancer in the United States: An Analysis of Racial Disparities in Access and QualityEdward Christopher Dee, Neil K Taunk, Fumiko L Chino, et al.
International Journal of Radiation Oncology, Biology, Physics|October 25, 2025
Integration of Habitat Risk Score in Radiation Therapy for Prostate CancerEvangelia I Zacharaki, Adrian L Breto, Ahmad Algohary, et al.
European Urology|December 18, 2018
Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate CancerDavid D Yang, Brandon A Mahal, Vinayak Muralidhar, et al.
Brachytherapy|August 17, 2016
Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancerYu-Wei Chen, Vinayak Muralidhar, Brandon A Mahal, et al.
Urologic Oncology|January 5, 2016
Asian Americans and prostate cancer: A nationwide population-based analysisGrace F Chao, Nandita Krishna, Ayal A Aizer, et al.
The Lancet. Digital Health|May 26, 2023
Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysisSmruthy Sivakumar, Jessica K Lee, Jay A Moore, et al.
The American Journal of Medicine|March 21, 2018
Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent DivorceKathryn T Dinh, Ayal A Aizer, Vinayak Muralidhar, et al.
Clinical Genitourinary Cancer|May 3, 2017
Disparities in the Receipt of Local Treatment of Node-positive Prostate CancerVinayak Muralidhar, Brandon A Mahal, Brent S Rose, et al.
International Journal of Radiation Oncology, Biology, Physics|December 4, 2020
Factors Influencing Noncompletion of Radiation Therapy Among Men With Localized Prostate CancerEdward Christopher Dee, Vinayak Muralidhar, Melaku A Arega, et al.
Pageof 21